Near-physiological temperature is central to this approach because the solution is delivered warm rather than as a cold fluid. During reduced cardiac activity, that temperature supports myocardial preservation and helps limit metabolic stress. This matters when the heart later undergoes reperfusion, the restoration of coronary flow, and must recover function after the operative period.
Potassium induces diastolic arrest by depolarizing cardiac muscle, changing the electrical state that normally supports contraction. The resulting standstill reduces ongoing cardiac activity while the surgeon performs the operation. This mechanism is important because it temporarily quiets the myocardium and creates conditions in which protective delivery through the coronary circulation can be maintained.
Blood-based components can supply oxygen and nutrients while cardiac activity is reduced and coronary flow is limited. Their role complements potassium-mediated arrest by supporting the myocardium during the protected interval rather than treating arrest as the only preservation mechanism. This is particularly relevant when the surgical procedure requires continued myocardial support during cardiopulmonary bypass.
Administration occurs through the coronary circulation while the patient is supported by cardiopulmonary bypass. This route places the protective fluid directly within the vessels supplying the myocardium, allowing the solution to reach the heart during the period of surgical cardiac arrest. The delivery strategy therefore connects myocardial protection with the bypass-supported operative workflow.
Repeated doses may be used because myocardial protection is needed throughout the interval of cardiac surgery, not only at its beginning. The solution can be administered again during the procedure to continue potassium-associated arrest and support the protective environment. This repeated delivery is coordinated with cardiopulmonary bypass and the ongoing period of reduced coronary flow.
By limiting myocardial injury and controlling metabolic stress during the operation, this strategy may contribute to improved cardiac function after reperfusion. The relevant outcome is not simply temporary cardiac arrest, but preservation of the myocardium through the surgical interval and support for recovery when coronary flow and cardiac activity are restored.